Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 FY- Text added to 2020 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accessibility, Africa, AstraZeneca, Bauhinia, BCHT, Bio, biomedical, Brazil, Brazilian, broadening, Bronze, Butantan, CDH, Chengdu, Chile, cloud, Cogency, cohort, commensurate, conglomerate, CoronaVac, Daxing, driven, East, elderly, eleven, embedded, ESOP, Everbright, factory, Farma, field, Floor, forecasted, formal, GCP, Griffin, Guangdong, hospitalized, Ilac, immunobiologic, implied, Indonesia, Inline, Instituto, Keygen, KEYMEN, Lancet, LS, machinery, Mediterranean, middle, MMPA, moderately, Pfizer, Pharmacopoeia, placebo, point, Prize, PT, Pte, randomized, randomly, rejecting, rest, rolling, Sanayi, Schema, screening, Sino, situation, slowdown, software, Star, Subtopic, Tianfu, Tic, Turkey, unusual, Utopia, Ve, viable, Walvax, worker, xi, Xiangrui, Yongda
Valuein 2019 FY filing- Value in 2020 FY filing
Original filings
Filing view